KELLY HOLT: Open Payments
NPI 1205169711 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 5 companies in 2025. Trend: 2023 $61 · 2024 $47 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| Lilly USA, LLC | 1 | $26 |
| Boston Scientific Corporation | 1 | $21 |
| PFIZER INC. | 1 | $15 |
Products named: EPKINLY, MOUNJARO, Saxenda, CDS - MCT/CEM Monitoring, Wegovy, IMBRUVICA, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
